Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Company Profile iShares Genomics Immunology and Healthcare Index ETF T.XDNA

XDNA seeks to provide long-term capital growth by replicating, to the extent possible, the performance, net of expenses, of an Index selected at the discretion of BlackRock Canada that is composed of securities of issuers that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering, as determinedby the Index Provider. XDNA currently seeks to replicate the performance of the NYSE FactSet Global Genomics and Immuno Biopharma Index. Under normal market conditions, XDNA will primarily invest in securities of one or more iShares ETFs and/or international equity securities.


Company Profile & Information (TSX:XDNA)

Showcase News Releases

Showcase news

Orford Mining Corp.
Orford Closes financing of $2.4 million
Gran Tierra Energy Inc.
Gran Tierra Energy Inc. Announces Second Quarter 2022 Results
Cybin Inc.
Cybin Announces Up to USD$35 Million At-The-Market Equity Program

More Showcase News Releases »